Portable Oxygen Concentrator Market Size, Share, Opportunities, And Trends By Product (Continuous Flow Portable Oxygen Concentrator, Pulse Flow Portable Oxygen Concentrator), By End User (Homecare Setting, Air Ambulance, Others), And By Geography - Forecasts From 2025 To 2030

The portable oxygen concentrator market is estimated to attain US$4.869 billion by 2030, growing at a CAGR of 11.23%, from US$2.860 billion in 2025.

A portable oxygen concentrator is a device which features a small, lightweight, and silent design and offers patients a continuous supply of oxygen. Hence, they offer applicability across multiple sectors, which majorly includes utilization in homecare settings, ambulances, and aero-ambulances. The portable oxygen concentrator ensures a higher oxygen output and it also helps in increasing the survival rate of the critical patients.

The demand for portable oxygen concentrators in the global market is expected to witness a significant increase fuelled with the increasing older population across the world as they offers multiple benefits to the older population such as increasing the body's ability to inhale pure oxygen. With the increasing age of individuals, the risk of various types of respiratory or pulmonary diseases like chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and other type of lung diseases increase drastically.

The World Bank, in its global population report, stated that in 2024, the total population aged 65 years and above was recorded at 804.475 million. This marked a major growth from 2021, when the total population aged 65 and above was recorded at 754.681 million, and about 778.122 million in 2022. 

What are the Portable Oxygen Concentrator Market Drivers?

• Growing global cases of respiratory diseases is propelling the market expansion

The increasing global cases of pulmonary or respiratory diseases are among the key factors propelling the growth of the global portable oxygen concentrator market during the estimated timeline. The global cases of various types of respiratory and lung diseases like COPD, emphysema, and chronic bronchitis witnessed major growth across the globe. The cases of respiratory diseases witnessed a growth majorly caused by various factors like pollution, age, and lifestyle of the individuals.

The American Lung Association in its report stated that in the USA, about 11.7 million adults are affected by COPD or chronic obstructive pulmonary disease. Similarly, the Centers for Disease Control and Prevention of the USA stated that in the nation, about 4.3% of the total population of the nation, in 2023, were diagnosed with COPD, emphysema, or chronic bronchitis. The agency further stated that in the nation, chronic lower respiratory disease, which includes asthma caused about 147,382 deaths, which is equal to about 44.2 deaths per 100,000 population of the nation. The agency stated that emphysema and bronchitis diseases in 2023 caused about 7,905 and 358 deaths respectively, whereas the other chronic lower respiratory diseases which excludes asthma caused 135,517 deaths. In the nation, asthma caused about 3,602 deaths, which is equivalent to 1.1 deaths per 100,000 population.

Similarly, Statistics Canada, in its report stated that the cases of deaths caused by various types of respiratory diseases also witnessed a constant growth. The agency stated that in 2021, about 311,640 deaths in the nation were caused by respiratory disease, which increased to 334,081 in 2022. Likewise, the same source also specified that the deaths caused by chronic lower respiratory diseases increased in the nation from 11,018 deaths in 2021 to 12,462 deaths in 2022. In 2023, the total number of deaths caused by chronic lower respiratory diseases was recorded at 12,994.

The cases of respiratory diseases in India also witnessed significant growth during the past few years. The major factor boosting the cases of pulmonary and respiratory diseases in the Indian market is the increasing pollution and rising consumption of tobacco. The National Institute of Health of the Indian Government in its report stated that air pollution in the nation caused about 25.6% of the total cases of chronic obstructive pulmonary disease or COPD, and tobacco is responsible for about 16.5% of the cases. The Indian Journal of Public Health in its report stated that in India, the total cases of COPD were estimated at 37.8 million. which is about 17.8% of the total global cases. The journal also stated that the cases of COPD in the nation contribute to about 27.3% of the global deaths, caused by COPD.

Furthermore, the Scottish Public Health Observatory under its Public Health Information for Scotland platform stated that in Scotland, the cases of COPD witnessed a major growth from 2018, to 2023. The agency further stated that in the nation, the total deaths caused by COPD in Scotland was recorded at 2.2% for males, whereas the death rate caused by COPD for women was recorded at 2.4%.

Segment Analysis of IGA Nephropathy Disease Treatment Market:

• Homecare Setting segment is estimated to hold major market share in the projected period

Portable oxygen concentrators, with the increasing prevalence of chronic respiratory diseases such as COPD and sleep apnea, have a growing user base within the elderly segment. The growing elderly population in various countries is anticipated to positively influence the market for portable oxygen concentrators in the coming years.

For instance, according to the World Health Organization (WHO), the demographic change in the global direction to an aging population is quickening, affecting healthcare, social structures, and economies more significantly. As of 2030, one in six people would be aged 60 years or older, the absolute number of older persons will increase from an estimated 1 billion people in 2020 to 1.4 billion. This trend will continue, with the population aged 60+ doubling to 2.1 billion by 2050. In addition, the number of people 80 or older is expected to triple during the same period, to 426 million. These changes only heighten the demand for robust systems that can accommodate the aging population, with progress in healthcare, and caregiving.

Moreover, the demand for portable oxygen concentrators is anticipated to propel, owing to properties such as ease of portability, low weight, and support of mobility making them appealing to both patients and caregivers, hence improving the quality of life in patients with a need for long-term oxygen therapy.

Additionally, the trend toward care at home, coupled with advances in telehealth and cost-cutting measures implemented in healthcare, drives further demand for portable oxygen concentrators in this segment. According to the U.S. Centers for Medicare & Medicaid Services, home healthcare services provided by independent freestanding agencies have experienced a 6.0% increase in 2022, with $132.9 billion in expenditures, a significant increase compared to the slight 0.3% growth seen in 2021.

The growth was mainly from higher spending from private health insurance, out-of-pocket sources, and Medicaid on home health care services, indicating an increased reliance on home-based care solutions. Conversely, growth in Medicare spending for these services slowed, indicating a shift in funding patterns. The rise in spending is further driven by the aging population, the growing burden of chronic illnesses, and a preference for cost-effective, patient-focused care delivered at home.  Increasing product launches in the portable oxygen concentrator market are anticipated to further propel the market in the coming years. For instance, in October 2024, Inogen, Inc., a leading medical technology company specializing in innovative respiratory products for homecare, announced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. The Rove 4 features an additional fourth flow setting, delivering up to 840 ml/min of medical-grade oxygen, all within a lightweight design of under 3 lbs. It offers three battery configurations, enabling up to 5 hours and 45 minutes of operation. This advanced design enhances versatility, empowering patients with greater flexibility to support their daily activities and improve their quality of life.

Moreover, the rising cases of chronic obstructive pulmonary disease (COPD) and asthma are anticipated to boost the demand for portable oxygen concentrators in the projected period. For instance, according to the Australian Bureau of Statistics, in 2022, 2.5% of the population (638,100 people) had been diagnosed with COPD, a prevalence that has remained relatively stable over the past decade (2.4% in 2011–12). Rates of COPD were similar between males (2.4%) and females (2.6%), but significantly higher among people aged 65 and over, at 7.0%. Current daily smokers had a notably higher chance of COPD (8.1%) compared with ex-smokers (4.4%) and never-smokers (1.6%). Most people with COPD (86.6%) also had two or more chronic conditions, illustrating its link with multimorbidity. Furthermore, 9.3% of adults reporting severe or very severe bodily pain reported having COPD, which further illustrates its quality-of-life implications.

Similarly, the cases of asthma are increasing rapidly, which is another reason boosting the demand for portable oxygen concentrators in the coming years. According to the Australian Bureau of Statistics, in 2022, an estimated just under 2.8 million people were living with asthma, which is a stable prevalence over the past decade: 10.2% in 2011–12. Females generally had higher rates of asthma than males (12.2% vs. 9.4%), except among children aged 0–14 years, when boys had a higher prevalence than girls (10.1% vs. 6.2%). This gender-based pattern in children has been consistent since 2001, which underscores differences in asthma prevalence across age and gender groups. Hence, these are some major factors, which might positively affect the portable oxygen concentrator market in the projected period.

What are the key geographical trends shaping the IGA Nephropathy Disease Treatment Market:

• The North America  is expected to dominate the market in the coming years

Portable oxygen concentrators form an integral part of long-term oxygen therapy as they reduce the gap between oxygen solutions availability and their usage for patients suffering from chronic obstructive pulmonary disease or lung cancer. Tackling such disease has become a major concern in the United States with various investments and initiatives being undertaken to bolster the development of required solutions.

According to the Lung Cancer Research Foundation, nearly 654,620 Americans have been diagnosed with lung cancer at some point in their lives, and the annual death count reaches up to 125,070 annually. Likewise, according to the “State of Lung Cancer Report 2023’ issued by the American Lung Association, nearly 238,000 people were diagnosed with lung cancer in 2023 which represented an increase of 1000 new cases in comparison to 2022.

Moreover, old age people are more prone to respiratory and lung disease and with the constant growth in the geriatric population of the United States, the probability of people getting diagnosed with some form of respiratory disease is also expected to grow. According to the Population Reference Bureau, by 2050 population aged 65 years and above will reach up to 82 million thereby signifying a remarkable growth of 47% over the population recorded in 2022. Hence the same source further specified that the percentage share of old age people will increase from 17% to 23% in the given period.

However, the ongoing developments in lung cancer treatment over the years have reduced the prevalence rate thereby providing a major scope for the usage of portable oxygen concentrators. As per the American Lung Cancer Association, the survival rate of Americans has improved by 26% over the past five years, with the federal government working on opportunities to increase cancer screening and increase access to required oxygen solutions for patients.

Moreover, major players operating in portable oxygen concentrators have established their base in the US market as they aim to optimize the growing opportunity. For instance, as per the 2023 annual report of Inogen Inc. of the total company revenue of US$315.600 million, the United States contributed US$226.3 million thereby constituting nearly 70% of the total revenue.

Furthermore, the company is also investing in new product launches with the recent development being made in October 2024, where the company introduced the “Rove 4” portable oxygen concentrator that is ideal for home care settings in the US market, Additionally, the company, in August 2023, showcased” Rove 6” portable oxygen concentrator in the US. Hence, such ongoing developments followed by constant efforts being made to reduce the mortality rate of lung cancer patients have paved the way for the future market expansion of long-term oxygen therapy solutions such as portable oxygen concentrators.

The Portable Oxygen Concentrator Market is analyzed into the following segments:

• By Product
  • Continuous Flow Portable Oxygen concentrator
  • Pulse Flow Portable Oxygen Concentrator
• By End-User
  • Homecare Setting
  • Air Ambulance
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Thailand
    • Taiwan
    • Indonesia
    • Others

---

1. Introduction

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits for the Stakeholders

2. Research Methodology  

2.1. Research Design

2.2. Research Process

2.3. Data Validation

3. Executive Summary

3.1. Key Findings

3.2. Analyst View

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Supplier

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. Portable Oxygen Concentrator Market By Product

5.1. Introduction

5.2. Continuous Flow Portable Oxygen Concentrator

5.3. Pulse Flow Portable Oxygen Concentrator

6. Portable Oxygen Concentrator Market By End-User

6.1. Introduction

6.2. Homecare Setting

6.3. Air Ambulance

6.4. Others

7. Portable Oxygen Concentrator Market By Geography 

7.1. Introduction

7.2. North America

7.2.1. By Product

7.2.2. By End-User

7.2.3. By Country

7.2.3.1. United States

7.2.3.2. Canada

7.2.3.3. Mexico

7.3. South America

7.3.1. By Product

7.3.2. By End-User

7.3.3. By Country

7.3.3.1. Brazil

7.3.3.2. Argentina

7.3.3.3. Others

7.4. Europe

7.4.1. By Product

7.4.2. By End-User

7.4.3. By Country

7.4.3.1. United Kingdom

7.4.3.2. Germany 

7.4.3.3. France

7.4.3.4. Italy

7.4.3.5. Spain

7.4.3.6. Others

7.5. Middle East and Africa

7.5.1. By Product

7.5.2. By End-User

7.5.3. By Country

7.5.3.1. Saudi Arabia

7.5.3.2. UAE

7.5.3.3. Others

7.6. Asia Pacific

7.6.1. By Product

7.6.2. By End-User

7.6.3. By Country

7.6.3.1. China

7.6.3.2. Japan

7.6.3.3. South Korea

7.6.3.4. India

7.6.3.5. Indonesia

7.6.3.6. Thailand

7.6.3.7. Taiwan

7.6.3.8. Others

8. Competitive Environment and Analysis

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. Company Profiles

9.1. Precision Medical Inc.

9.2. Nidek Medical Products Inc.

9.3. Philips Healthcare

9.4. Drive DeVilbiss international

9.5. Invacare Corporation

9.6. Chart Industries

9.7. Inogen Inc

9.8. Summit Oxygen international

9.9. Nareena Lifesciences Private Limited

9.10. Anand Medicaids

9.11. Hindustan Engineers

9.12. Global Medical Devices

9.13. EVOX, India

Precision Medical Inc.

Nidek Medical Products Inc.

Philips Healthcare

Drive DeVilbiss international

Invacare Corporation

Chart Industries

Inogen Inc

Summit Oxygen international

Nareena Lifesciences Private Limited

Anand Medicaids

Hindustan Engineers

Global Medical Devices

EVOX, India